Key result
In anesthetized rats, 4-aminopyridine activated both autonomic branches, revealing that sympathetic norepinephrine release dominates and prevents parasympathetic influence on heart rate in hypertensive rats.
Why the study?
Does 4-aminopyridine (4-AP) reveal altered autonomic control of heart rate, vascular tension, and epinephrine release in anesthetized spontaneously hypertensive rats compared to normotensive rats?
Population
130 male normotensive Wistar Kyoto rats and 131 male spontaneously hypertensive rats anesthetized with…
Comparison
Intravenous bolus injection of 4-aminopyridine… vs PBS-sham pre-treatment prior to 4-AP injection.
Design
Preclinical
Follow-up
25 minutes
Authors
Loading...
Animal data on sympathetic dominance in hypertension models warrant clinical caution; leaves open translation to human autonomic therapies.
Does 4-aminopyridine (4-AP) reveal altered autonomic control of heart rate, vascular tension, and epinephrine release in anesthetized spontaneously hypertensive rats compared to normotensive rats?
Simultaneous activation of the autonomic nervous system using 4-AP in anesthetized rats reveals a dominant sympathetic response and altered autonomic control mechanisms in spontaneously hypertensive rats.
Torill Berg (2011) studied Hypertension (animal model) (n=261). 4-aminopyridine (4-AP) vs. PBS (vehicle) and various autonomic blockers was evaluated on Heart rate and total peripheral vascular resistance (TPVR) response. In anesthetized rats, 4-aminopyridine activated both autonomic branches, revealing that sympathetic norepinephrine release dominates and prevents parasympathetic influence on heart rate in hypertensive rats.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: